DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of “Reduce” from Brokerages

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have been assigned an average recommendation of “Reduce” from the fifteen brokerages that are covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and two have given a buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is $15.1538.

Several brokerages have weighed in on XRAY. Robert W. Baird lowered their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Tuesday, December 16th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, October 8th. JPMorgan Chase & Co. cut their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research report on Friday, November 7th. Evercore ISI lowered their price target on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a research report on Wednesday, October 8th. Finally, Wells Fargo & Company dropped their price objective on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating on the stock in a research note on Friday, November 7th.

Insider Activity at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction on Monday, December 8th. The stock was sold at an average price of $11.14, for a total value of $915,708.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.50% of the company’s stock.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Arizona State Retirement System lifted its position in shares of DENTSPLY SIRONA by 1.4% during the third quarter. Arizona State Retirement System now owns 58,952 shares of the medical instruments supplier’s stock valued at $748,000 after buying an additional 807 shares during the last quarter. Public Employees Retirement System of Ohio raised its stake in shares of DENTSPLY SIRONA by 1.4% during the 2nd quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier’s stock worth $983,000 after acquiring an additional 861 shares in the last quarter. Gabelli Funds LLC lifted its position in DENTSPLY SIRONA by 1.0% during the first quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier’s stock valued at $1,464,000 after acquiring an additional 1,000 shares during the last quarter. True Wealth Design LLC boosted its stake in DENTSPLY SIRONA by 49.7% in the third quarter. True Wealth Design LLC now owns 3,557 shares of the medical instruments supplier’s stock valued at $45,000 after acquiring an additional 1,181 shares in the last quarter. Finally, Sivia Capital Partners LLC boosted its stake in DENTSPLY SIRONA by 5.3% in the third quarter. Sivia Capital Partners LLC now owns 25,774 shares of the medical instruments supplier’s stock valued at $327,000 after acquiring an additional 1,293 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock opened at $11.31 on Friday. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99. The stock has a market cap of $2.26 billion, a price-to-earnings ratio of -2.56, a price-to-earnings-growth ratio of 0.82 and a beta of 1.01. The firm has a 50-day moving average of $11.56 and a two-hundred day moving average of $13.48. DENTSPLY SIRONA has a 1 year low of $9.85 and a 1 year high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.08). DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. The company had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.33 million. During the same period in the prior year, the firm posted $0.50 EPS. The business’s revenue was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. On average, research analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 9th. Shareholders of record on Friday, December 26th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 5.7%. The ex-dividend date of this dividend is Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -14.48%.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.